Mesoblast (NASDAQ:MESO) Bolsa

Mesoblast

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AEMD

APCX

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

DALN

DSGN

ELAB

KULR

LITM

PTPI

QNTM

SGMO

SLXN

VRAX

Acciones de Sangamo Therapeutics suben un 19,5% tras un nuevo acuerdo. Descubre los mayores ganadores y perdedores de hoy.

Acciones de Sangamo Therapeutics (SGMO) suben alrededor de un 20%; 20 acciones que se mueven en el premercado

The Special Committee of the Board of Directors of FONAR Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FONR#NASDAQ">FONR</a>) ("FONAR"), The Inventor of MR Scanning&#x2122;, today confirmed receipt of a supplemental proposal letter, dated July 17, 2025, from the Proposed Acquisition Group led by Timothy Damadian. The supplemental letter states that the Proposed Acquisition Group is contemplating the pursuit of a plan to acquire all of the outstanding shares capital stock of FONAR not currently owned by the Proposed Acquisition Group, at a price of $17.25 per share in cash. The letter states that the proposed share price represents a premium of approximately 27% over the average closing price of the Common Stock for the 90 trading day trading period ending on June 30, 2025. A copy of the Proposed Acquisition Group's supplemental letter is attached as an exhibit to the Group's Amended Schedule 13D/A No.1, which is available for review by the public on the Securities and Exchange Commission's website.
The Special Committee, composed of independent and disinterested directors, was formed in response to interest expressed by the Proposed Acquisition Group in exploring a possible transaction in a letter delivered to the FONAR Board and dated July 7, 2025. The Special Committee will carefully review the supplemental proposal in consultation with independent financial and legal advisors to determine the course of action that is in the best interest of FONAR and all shareholders. No action is required by FONAR shareholders at this time.
FONAR cautions its shareholders and others considering trading in FONAR's securities that FONAR has only recently received the supplemental proposal letter and no decisions have been made with respect to FONAR's response to the proposed transaction. The proposal constitutes only an indication of interest by the Proposed Acquisition Group and does not constitute a binding commitment.
There can be no assurance that any agreement will be executed or that the transaction contemplated in the proposal or any other transaction will be approved or consummated. No agreement, arrangement or understanding between FONAR and the Proposed Acquisition Group relating to any proposed transaction will be created unless definitive documentation is executed and delivered by the appropriate parties.
FONAR does not anticipate making any further public statements about this matter or the activities of the Special Committee unless and until either it enters into a definitive agreement for a transaction or the Special Committee determines that no such transaction will be effected.

FONR

FONAR Receives $17.25/Share Cash Buyout Proposal From Timothy Damadian-Led Group; Special Committee Will Carefully Review The Supplemental Proposal In Consultation With Independent Financial And Legal Advisors To Determine The Course Of Action That Is In The Best Interest Of Fonar And All Shareholders

Virax Biolabs Received Nasdaq Noncompliance Letter

Management

ICMB

Investcorp Credit Management CFO Walter Tsin Resigns Effective July 16, 2025; Robert Muns Appointed As CFO

Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) has outperformed the market over the past 10 years by 4.11% on an annualized basis producing an average annual return of 15.67%. Currently, Texas Instruments has a market capitalization of $196.79 billion. 
Buying $100 In TXN: If an investor had bought $100 of TXN stock 10 years ago, it would be worth $439.39 today based on a price of $216.62 for TXN at the time of writing.
<h3>Texas Instruments's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752869721_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today

<a href="https://www.sec.gov/Archives/edgar/data/1976908/000110465925069022/tm2521218d1_6k.htm" title="https://www.sec.gov/Archives/edgar/data/1976908/000110465925069022/tm2521218d1_6k.htm">https://www.sec.gov/Archives/edgar/data/1976908/000110465925069022/tm2521218d1_6k.htm</a>

JDZG

JIADE Regained Nasdaq Compliance

General

SDRL

On July 11, High Court Rules In Favor Of Claimant For Dispute Related To JV In Angola;  Judgment Impact On Adj EBITDA For FY Expected To Be $10M

Amcon Distributing (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DIT#AMEX">DIT</a>) reported quarterly earnings of $2.13 per share. This is a 13.41 percent decrease over earnings of $2.46 per share from the same period last year. The company reported $739.615 million in sales this quarter. This is a 3.03 percent increase over sales of $717.852 million the same period last year.

Earnings

Amcon Distributing Q3 EPS $2.13 Down From $2.46 YoY, Sales $739.615M Up From $717.852M YoY

Multinational payment card services provider Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) continues to perform as a consistently reliable blue-chip enterprise. On a year-to-date basis, V stock has gained just over 10%, which is a modest but noticeable improvement over the benchmark S&amp;P 500 index. At the same time, broader economic concerns cloud the company, which is set to release its results for the <a href="https://www.benzinga.com/quote/V/earnings">fiscal third quarter</a> near month's end. Still, the unusual circumstances may present a bullish edge for speculators.
On July 29, Visa is scheduled to disclose its financial results, with Wall Street analysts anticipating earnings per share of $2.83 on revenue of $9.82 billion. In the year-ago quarter, the financial services giant posted earnings of $2.42 per share with a top-line print of $8.9 billion. What should boost confidence for investors is that Visa commands a long history of earnings beats.
That said, it's also interesting that the sole hiccup since the fiscal third quarter of 2020 materialized one year ago, when Visa suffered a slight miss against revenue expectations. Could lightning strike twice for the bears?
It's possible and the pessimists might argue that it's probable. Consumers have been <a href="https://www.benzinga.com/news/25/04/44916124/frozen-pizza-sales-surge-like-2009-recession-as-americans-cut-back-on-dining-out-amid-economic-strain">pivoting toward lower-cost food alternatives</a>, a dynamic that echoes the 2009 recession. Unfortunately for the company, broader headwinds have <a href="https://www.benzinga.com/quote/V">impacted its revenue streams</a>, suggesting that Visa is vulnerable to economic softness — despite the counterargument that credit cards can allow holders to stretch their finances.
Nevertheless, the <a href="https://www.benzinga.com/markets/large-cap/25/07/46365557/visa-vs-mastercard">broader transition toward digital payment solutions</a> has so far bolstered V stock. While there are consumers that still prefer to use cash, the emphasis today is on greater convenience and wider integration with digital platforms. Overall, the idea is that this massive tailwind can help Visa ride out the present economic turbulence.
<h2 class="wp-block-heading">Establishing The Benchmark For V Stock And Beating It</h2>
While the financial services provider has performed well this year, V stock has admittedly encountered a downdraft. Since June 11, the security has struggled within a bearish trend channel, raising legitimate questions about its forward trajectory. Still, the consolidation may be signaling for a possible reversal.
First, it's important to establish a baseline for V stock, which would be its null hypothesis: the expected performance of the security assuming no mispricing. Since January 2019, the chance that a one-week long position in Visa stock will be profitable is 56.43%. Therefore, an alternative hypothesis must be able to beat this benchmark.
In this case, our alternative hypothesis is that because V stock is printing a rare quantitative signal, the probability of upside is 78.57%.
To arrive at the above conclusion, you cannot simply look at the share price and make such a determination. Instead, we can discretize price action into market breadth, essentially converting it into sequences of accumulative and distributive sessions. In this manner, we're dealing with root demand; that is, at the end of the session, was the market a net buyer or net seller?
By compressing price discovery into simple up weeks and down weeks, we can more easily identify recurring patterns — and more importantly, the likelihood of transition from one sequence to another. Conducting this exercise for Visa stock across 10-week intervals gives us the following demand profile:
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>L10 Category</td>
<td>Sample Size</td>
<td>Up Probability</td>
<td>Baseline Probability</td>
<td>Median Return if Up</td>
</tr>
<tr>
<td>2-8-D</td>
<td>6</td>
<td>50.00%</td>
<td>56.30%</td>
<td>2.04%</td>
</tr>
<tr>
<td>3-7-D</td>
<td>20</td>
<td>55.00%</td>
<td>56.30%</td>
<td>3.29%</td>
</tr>
<tr>
<td>3-7-U</td>
<td>4</td>
<td>50.00%</td>
<td>56.30%</td>
<td>1.70%</td>
</tr>
<tr>
<td>4-6-D</td>
<td>38</td>
<td>47.37%</td>
<td>56.30%</td>
<td>3.37%</td>
</tr>
<tr>
<td>4-6-U</td>
<td>14</td>
<td>64.29%</td>
<td>56.30%</td>
<td>1.26%</td>
</tr>
<tr>
<td>5-5-D</td>
<td>32</td>
<td>50.00%</td>
<td>56.30%</td>
<td>2.80%</td>
</tr>
<tr>
<td>5-5-U</td>
<td>39</td>
<td>61.54%</td>
<td>56.30%</td>
<td>1.91%</td>
</tr>
<tr>
<td>6-4-D</td>
<td>13</td>
<td>76.92%</td>
<td>56.30%</td>
<td>1.69%</td>
</tr>
<tr>
<td>6-4-U</td>
<td>61</td>
<td>54.10%</td>
<td>56.30%</td>
<td>1.33%</td>
</tr>
<tr>
<td>7-3-U</td>
<td>61</td>
<td>55.74%</td>
<td>56.30%</td>
<td>1.43%</td>
</tr>
<tr>
<td>8-2-U</td>
<td>26</td>
<td>57.69%</td>
<td>56.30%</td>
<td>1.47%</td>
</tr>
<tr>
<td>9-1-U</td>
<td>5</td>
<td>20.00%</td>
<td>56.30%</td>
<td>4.96%</td>
</tr>
</tbody>
</table>
</figure>
In the trailing two months, V stock is printing a "6-4-D" sequence: four up weeks, six down weeks, with a negative trajectory across the 10-week period. It's a rare sequence, having materialized only 14 times since January 2019. However, the takeaway, again, is that in 76.92% of cases, the following week's price action results in upside, with a median return of 1.69%.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/18151509/Visa-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-992129" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/18151509/Visa-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/18151509/Visa-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/18151509/Visa-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/18151509/Visa-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Assuming that V stock closes around $349, bullish speculators may anticipate a quick push to $354.90, possibly to $355 given the psychological importance. From here, if the bulls maintain control over the next four weeks, a push toward $361 is reasonable based on an analysis of past analogs.
<h2 class="wp-block-heading">Taking A Shot On Visa</h2>
Armed with the market intelligence above, there are two ways to play V stock. First, you may consider the 352.50/355 bull call spread expiring Aug. 1. This transaction involves buying the $352.50 call and simultaneously selling the $355 call, for a net debit paid of $125 (the most that can be lost in the trade). Should V rise through the short strike price ($355) at expiration, the maximum reward is also $125, a 100% payout.
With the above trade, you have the option of pulling out ahead of earnings if conditions justify it or wait till after the earnings disclosure.
Another idea to consider is the 355/360 bull spread expiring Aug. 15. This transaction requires a net debit of $215 at time of writing. However, if Visa stock manages to rise through the short strike price at expiration, the maximum reward is $285, a payout of roughly 133%.
Of course, the above trade hinges on the viability of the 6-4-D sequence and its projected statistical response. Running a one-tailed binomial test reveals a p-value of 7.76. This means that there's a 7.76% probability that V stock can rise 76.92% on a frequency basis by random chance rather than as a "consequence" of the 6-4-D sequence.
Scientifically, this does not meet the threshold of statistical significance, where the p-value cutoff is 5%. However, given the open-system nature of the stock market, this is unquestionably an empirically unusual quant signal — one that could provide an edge for adventurous speculators.
The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.
Read More:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/options/25/07/46480506/wmt-stock-walmart-science-mispriced-options">Options Corner: Use Science To Take Advantage Of Walmart&#8217;s Mispriced Derivatives</a></li>
</ul>
Photo: Shutterstock

Equities

Long Ideas

Options

Options Corner: Visa Is Setting Up A Statistical Breakout That You Don't Want To Miss

HOOK

HOOKIPA Pharma To Voluntarily Delist And Deregister

As previously disclosed, on February 18, 2025, Society Pass Incorporated (the "Company") received written notice (the "Delist Notice") from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, based upon the Company's continued non-compliance with Rule 5550(b)(2) which requires that the Company shall maintain at least $2,500,000 stockholders' equity (the "Equity Rule"), the Nasdaq staff determined to delist the Company's common stock from the Nasdaq Capital Market effective February 27, 2025 unless the Company timely requested an appeal of this determination before the Nasdaq Hearings Panel (the "Panel"). The Company timely requested a hearing (the "Hearing") before the Panel, which stayed the suspension of the Company's common stock pending the Panel's decision, and the Hearing was held on April 1, 2025. On April 9, 2025, the Panel issued a decision that granted the Company's request to continue its listing on Nasdaq based on the information presented. The Panel has determined to grant the Company's request for an exception until June 30, 2025. On July 15, 2025, the Panel issued an amended decision to further grant the Company's request for an exception until August 18, 2025. The compliance plan was conditioned on (i) the Company filing a Form 8-K describing the transactions undertaken by the Company to achieve compliance and demonstrate long-term compliance with the Equity Rule, and by providing an indication of its equity following those transactions; and (ii) the Company will evidence compliance with all applicable criteria for continued listing on the Nasdaq Capital Market.

SOPA

Society Pass Granted Nasdaq Extension Until August 18, 2025 To Regain Compliance

ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) today announced that it has applied to the Alberta Securities Commission (ASC), as principal regulator, and the Ontario Securities Commission (OSC) for a joint order (the Order Sought) to cease to be a reporting issuer in all jurisdictions of Canada in which it is a reporting issuer. If the Order Sought is granted by the ASC and the OSC, ConocoPhillips will cease to be a reporting issuer in any jurisdiction in Canada.
Notwithstanding a decision that ConocoPhillips is not a reporting issuer in Canada, ConocoPhillips will continue to file all financial statements and other continuous disclosure materials required to be filed by it in accordance with the applicable securities laws of the United States and the rules of the New York Stock Exchange (NYSE). All such continuous disclosure documents of ConocoPhillips are publicly available to all security holders of ConocoPhillips under ConocoPhillips' profile at <a href="https://www.sec.gov/">www.sec.gov</a>. ConocoPhillips' security holders residing in Canada will continue to receive copies of the continuous disclosure documents that are required to be delivered to security holders in the United States, in the same manner and at the same time as is required under the applicable securities laws of the United States and the rules of the NYSE.

ConocoPhillips Applies To Cease Canadian Reporting Issuer Status Through Joint ASC And OSC Order

Wall Street extended its historic rally this week, with major benchmarks such as the S&amp;P 500 and the tech-heavy Nasdaq 100 hitting fresh all-time highs, as strong corporate earnings, robust economic data and AI-fueled tech momentum continued <a href="https://www.benzinga.com/markets">to boost investor optimism.</a>
Big banks beat earnings estimates, setting a strong tone for the season. Airlines and consumer-focused giants also impressed.
Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) and PepsiCo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) reported their best trading weeks of the year, further supporting the confidence that solid consumer demand is driving margins across sectors.
Economic strength was underscored by June's retail sales data, which showed a 0.6% monthly increase — crushing economists&#8217; forecast of 0.1% — while jobless claims dropped to 221,000, their <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46467952/us-retail-sales-june-2025-fed-trump-inflation-consumer">lowest level since April.</a>
Investors appear to be buying into a &#8220;Goldilocks&#8221; scenario, where growth is strong enough to support profits but not so strong as to trigger new inflation fears. June's inflation data came in broadly lower than expected, marking a sharp turnaround from the stagflation concerns that gripped the market in the first quarter.
Since the post-tariff lows in April, the S&amp;P 500 has surged 27%, a rally that now ranks among the sharpest three-month advances ever.
Read also: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46426381/sp500-rally-investor-sentiment-2025">S&amp;P 500 Defies Odds With Rare Rally — But &#8216;Toppy&#8217; Sentiment Creeps In</a>
NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) remains the epicenter of the tech rally. Its shares have nearly doubled since April, driven by surging demand for AI chips from cloud giants like Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
Nvidia's rally has helped lift the "Magnificent Seven" — including Microsoft Corp., Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon.com Inc., Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) — to a combined $18.5 trillion market cap, surpassing <a href="https://www.benzinga.com/markets/economic-data/25/07/46477275/wall-street-big-7-are-now-bigger-than-chinas-entire-economy">China's entire nominal GDP.</a>
Despite the economic strength, President Donald Trump has renewed his attacks on Fed Chair Jerome Powell, calling for immediate rate cuts. He even reportedly floated the idea of firing Powell before <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46454852/trump-fed-powell-odds-inflation-markets">backing off the proposal.</a>
Meanwhile, Fed Gov. Christopher Waller — a potential candidate to replace Powell next year — said he's willing to cut rates by <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46491573/waller-fed-chair-trump-rate-cut-july">the end of July.</a> The Fed meeting on July 30 now carries heightened political stakes, with growing signs of internal divisions.
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46496809/magnificent-7-stocks-wall-streets-estimates-google-alphabet-microsoft">These Two Magnificent 7 Stocks Are About To Hit Overdrive — And Wall Street&#8217;s Getting Excited </a></li>
</ul>
Photo: Shutterstock

Analyst Color

Government

Large Cap

Macro Economic Events

Regulations

Economics

Federal Reserve

Analyst Ratings

Tech

AAPL

AMZN

GOOGL

MSFT

NVDA

TSLA

Wall Street Sets New Records As Magnificent Seven Valuation Tops $18.5 Trillion: This Week In Markets

<a href="https://www.bloomberg.com/news/articles/2025-07-18/paramount-suitor-meets-with-fcc-chairman-seeking-ok-for-deal?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-18/paramount-suitor-meets-with-fcc-chairman-seeking-ok-for-deal?embedded-checkout=true</a>

PARA

'Paramount Suitor Meets With FCC Chairman, Seeking OK for Deal'- Bloomberg

<a href="https://www.wsj.com/politics/national-security/trump-ukraine-weapons-shipment-priority-be11f155" title="https://www.wsj.com/politics/national-security/trump-ukraine-weapons-shipment-priority-be11f155">https://www.wsj.com/politics/national-security/trump-ukraine-weapons-shipment-priority-be11f155</a>

Politics

Global

'U.S. Reorders Arms Deliveries to Free Up More Patriots for Ukraine' - WSJ Exclusive

Across the recent three months, 9 analysts have shared their insights on Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $47.11, a high estimate of $54.00, and a low estimate of $37.00. This current average reflects an increase of 8.47% from the previous average price target of $43.43. 
<img src="https://www.benzinga.com/files/images/story/2025/1752868895_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Toast is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Matthew Coad</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$50.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Nate Svensson</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$54.00</td>
<td>-</td>
</tr>
<tr>
<td>Matthew Coad</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$48.00</td>
<td>-</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Josh Baer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$50.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$46.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Clarke Jeffries</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$37.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Peter Heckmann</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$42.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Toast. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Toast compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Toast's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Toast's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TOST/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Toast analyst ratings.</a>
<h2>About Toast</h2>
Toast is a US-based restaurant technology company that provides point-of-sale, payment processing, and various software services to 140,000 restaurant locations across the United States as of the end of March 2025. The firm generates sales from software subscription fees, a percentage take rate from each financial transaction it processes, loan origination and servicing fees from its Toast Capital arm, and hardware installation and professional services. Unlike competitors, Toast intermediates every payment transaction on its platform; it processed some $159 billion in gross platform volume in 2024. The firm's product offerings span point-of-sale systems, inventory and payroll management, delivery integration, e-commerce ordering, reservation management, and loyalty programs.
<h3>Toast: Financial Performance Dissected</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Toast's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 24.37%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 4.19%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 3.48%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Toast's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.25%, the company showcases efficient use of assets and strong financial health.
Debt Management: Toast's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.01.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TOST

Expert Outlook: Toast Through The Eyes Of 9 Analysts

Across the recent three months, 8 analysts have shared their insights on Baidu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $107.88, with a high estimate of $140.00 and a low estimate of $81.00. This current average represents a 4.11% decrease from the previous average price target of $112.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1752868884_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Baidu among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jiong Shao</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$81.00</td>
<td>$84.00</td>
</tr>
<tr>
<td>Alicia Yap</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Thomas Chong</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Eddie Leung</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Alicia Yap</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$138.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Jiong Shao</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$84.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Fawne Jiang</td>
<td>Benchmark</td>
<td>Lowers</td>
<td>Buy</td>
<td>$120.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Jiong Shao</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$90.00</td>
<td>$95.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Baidu. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Baidu compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Baidu's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Baidu's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BIDU/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Baidu analyst ratings.</a>
<h2>Discovering Baidu: A Closer Look</h2>
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
<h3>Breaking Down Baidu's Financial Performance</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Baidu's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 2.98%. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Communication Services sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Baidu's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 23.78%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Baidu's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.89%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Baidu's ROA stands out, surpassing industry averages. With an impressive ROA of 1.75%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Baidu's debt-to-equity ratio is below the industry average at 0.38, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIDU

Where Baidu Stands With Analysts

Trading Halt: Halted at 4:01:00 p.m. ET - Trading Halt: Halt News Pending

Financial giants have made a conspicuous bullish move on Duolingo. Our analysis of options history for Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>) revealed 15 unusual trades.
Delving into the details, we found 60% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $896,740, and 6 were calls, valued at $324,960.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $290.0 to $490.0 for Duolingo over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Duolingo's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Duolingo's substantial trades, within a strike price spectrum from $290.0 to $490.0 over the preceding 30 days.
<h3>Duolingo Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752868861_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DUOL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$22.2</td>
<td>$19.2</td>
<td>$20.4</td>
<td>$330.00</td>
<td>$510.0K</td>
<td align="right">1</td>
<td align="right">250</td>
</tr>
<tr>
<td>DUOL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.2</td>
<td>$14.5</td>
<td>$14.5</td>
<td>$400.00</td>
<td>$101.5K</td>
<td align="right">511</td>
<td align="right">77</td>
</tr>
<tr>
<td>DUOL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$45.6</td>
<td>$45.3</td>
<td>$45.3</td>
<td>$380.00</td>
<td>$86.0K</td>
<td align="right">5</td>
<td align="right">34</td>
</tr>
<tr>
<td>DUOL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/20/26</td>
<td>$80.7</td>
<td>$80.0</td>
<td>$80.0</td>
<td>$400.00</td>
<td>$80.0K</td>
<td align="right">27</td>
<td align="right">16</td>
</tr>
<tr>
<td>DUOL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$34.5</td>
<td>$33.7</td>
<td>$33.7</td>
<td>$380.00</td>
<td>$67.4K</td>
<td align="right">0</td>
<td align="right">20</td>
</tr>
</tbody>
</table>

<h3>About Duolingo</h3>
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
Having examined the options trading patterns of Duolingo, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Duolingo Standing Right Now?</h3>
<ul>
<li>With a trading volume of 784,233, the price of DUOL is down by -1.09%, reaching $358.0.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 19 days from now.</li>
</ul>
<h3>Expert Opinions on Duolingo</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $513.75.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Buy rating for Duolingo, targeting a price of $500. 
&#x2A; Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for Duolingo, targeting a price of $480. 
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Duolingo with a target price of $500. 
&#x2A; An analyst from Argus Research has revised its rating downward to Buy, adjusting the price target to $575. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Duolingo options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

DUOL

Duolingo Options Trading: A Deep Dive into Market Sentiment

In the preceding three months, 13 analysts have released ratings for Texas Roadhouse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXRH#NASDAQ">TXRH</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $193.69, along with a high estimate of $220.00 and a low estimate of $164.00. This upward trend is apparent, with the current average reflecting a 1.21% increase from the previous average price target of $191.38.
<img src="https://www.benzinga.com/files/images/story/2025/1752868858_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Texas Roadhouse by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sara Senatore</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$219.00</td>
<td>$203.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$189.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>John Glass</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$205.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Gregory Francfort</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Buy</td>
<td>$210.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Jake Bartlett</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$212.00</td>
<td>$201.00</td>
</tr>
<tr>
<td>Jim Salera</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$220.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Christine Cho</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$205.00</td>
<td>$184.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$175.00</td>
<td>$179.00</td>
</tr>
<tr>
<td>Dennis Geiger</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$200.00</td>
<td>$210.00</td>
</tr>
<tr>
<td>Jon Tower</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$164.00</td>
<td>$213.00</td>
</tr>
<tr>
<td>Jeffrey Bernstein</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$179.00</td>
<td>$178.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>$175.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Texas Roadhouse. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Texas Roadhouse compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Texas Roadhouse's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Texas Roadhouse's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TXRH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Texas Roadhouse analyst ratings.</a>
<h2>Delving into Texas Roadhouse's Background</h2>
Texas Roadhouse Inc is a restaurant company operating predominantly in the casual dining segment. The company manages its restaurant and franchising operations by concept and, as a result, has identified Texas Roadhouse, Bubba's 33, Jaggers, and retail initiatives as separate operating segments. In addition, it has identified Texas Roadhouse and Bubba's 33 as reportable segments. Maximum revenue for the company is generated from the Texas Roadhouse segment, which is a moderately priced, full-service, casual dining restaurant concept offering steaks, a selection of ribs, seafood, chicken, pork chops, pulled pork, vegetable plates, and an assortment of hamburgers, salads, and sandwiches.
<h3>Texas Roadhouse's Financial Performance</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Texas Roadhouse showcased positive performance, achieving a revenue growth rate of 9.57% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Texas Roadhouse's net margin is impressive, surpassing industry averages. With a net margin of 7.85%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Texas Roadhouse's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 8.3%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Texas Roadhouse's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.56% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.66.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TXRH

Analyst Expectations For Texas Roadhouse's Future

Investors with a lot of money to spend have taken a bullish stance on Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TEM, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 31 uncommon options trades for Tempus AI.
This isn't normal.
The overall sentiment of these big-money traders is split between 48% bullish and 25%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $2,006,631, and 22 are calls, for a total amount of $1,371,060.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $80.0 for Tempus AI over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tempus AI's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tempus AI's whale activity within a strike price range from $45.0 to $80.0 in the last 30 days. 
<h3>Tempus AI 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752868855_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$5.9</td>
<td>$5.7</td>
<td>$5.71</td>
<td>$55.00</td>
<td>$1.5M</td>
<td>2.2K</td>
<td>12</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$4.7</td>
<td>$4.5</td>
<td>$4.5</td>
<td>$65.00</td>
<td>$225.6K</td>
<td>4.0K</td>
<td>743</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$4.6</td>
<td>$4.4</td>
<td>$4.5</td>
<td>$65.00</td>
<td>$211.5K</td>
<td>4.0K</td>
<td>1.9K</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$3.7</td>
<td>$3.5</td>
<td>$3.6</td>
<td>$65.00</td>
<td>$126.0K</td>
<td>4.0K</td>
<td>3.5K</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$18.5</td>
<td>$18.4</td>
<td>$18.4</td>
<td>$70.00</td>
<td>$112.2K</td>
<td>321</td>
<td>72</td>
</tr>
</tbody>
</table>

<h3>About Tempus AI</h3>
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
In light of the recent options history for Tempus AI, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Tempus AI</h3>
<ul>
<li>With a trading volume of 7,404,791, the price of TEM is down by -0.16%, reaching $60.55.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 18 days from now.</li>
</ul>
<h3>What The Experts Say On Tempus AI</h3>
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $72.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Guggenheim continues to hold a Buy rating for Tempus AI, targeting a price of $75. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on Tempus AI with a target price of $70. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tempus AI with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Looking At Tempus AI's Recent Unusual Options Activity

Press Releases

Mesoblast Allogeneic Cell Therapy Products Are Designated 'U.S. Country of Origin' and Not Subject to U.S. Tariffs

Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives

Mesoblast Appoints Corporate Finance Leader Lyn Cobley To Board

Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2025

Health Care

FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil®

Mesoblast Maintains Momentum With FDA on Accelerated Approval Pathway for Revascor® in Ischemic Heart Failure and Label Extension for Ryoncil® in Adults With GvHD

Four Rising Stars Driving the Next Wave of Stem Cell and Gene Therapy Innovation

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure

Small Caps, Big Potential: Regenerative Medicine Stocks Positioned for Growth

Successful Commercial Launch of Ryoncil®

ADIA

CRSP

FATE

LCTX

Arcutis Biotherapeutics, Inc. - Common stock

Arcutis Biotherapeutics

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Cidara Therapeutics

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Cogent Biosciences

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Dyne Therapeutics

89bio

Amicus Therapeutics

GRAIL

IDEAYA Biosciences

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Disc Medicine

Janux Therapeutics

Mesoblast Limited - American Depositary Shares

MannKind

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

ARS Pharmaceuticals

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Vericel

Veracyte

Vera Therapeutics, Inc. - Class A Common Stock

Vera Therapeutics

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Piper Sandler

Maxim Group

Chardan Capital

Screenshot 2024-11-15 at 7.50.34 PM

Biotech

BCLI

BRTX

LGVN

Presenting Encouraging Data, Acquiring Licenses, Issuing Patents And More – BioRestorative&#39;s Inroads Bringing Its Stem Cell Therapies To Market

Comments

Mesoblast

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL